Pre-pregnant gene expression signatures can be potential biomarkers to predict perinatal outcomes of RA
Increased bone morphogenetic protein receptor type 2 expression may enhance osteoblast differentiation in ankylosing spondylitis
Serum bilirubin level may function as a promising biomarker of interstitial lung disease in primary Sjögren’s syndrome
Post-marketing safety study demonstrates the safety and efficacy of baricitinib in moderate-to-severe RA patients
Serum metabolite signature panel may serve as a potential biomarker for the early clinical diagnosis of RA
Oral Hydroxychloroquine is safe and effective in treating primary Sjögren’s syndrome-related dry eye disease
